Stem Cell Therapy Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, South Korea, Brazil, Mexico, Saudi Arabia, UAE, South Africa), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025
Report ID: GMI3331
Stem Cell Therapy Market size is expected to grow significantly from 2019 to 2025.
Rising demand for organ transplantation will boost the stem cell therapy market in coming years. Stem cells have the ability of self-renewal, differentiation and pluripotency that are widely used for the treatment of traumatic brain injury, Parkinson’s disease, blindness, wound healing and Crohn’s disease. Moreover, hematopoietic stem cell transplantation has been successfully used in the treatment of leukemia. Such wide-ranging applications of stem cell therapy fosters industry growth.
From past few years stem cell banking is gaining more importance in the industry due to technological advancements. Additionally, growing awareness among people regarding stem cell storage worldwide should upsurge stem cell therapy industry revenue size. Furthermore, rising government initiatives and support for stem cell banking will further enhance the business growth. However, ethical concerns related the storage of embryonic stem cell may obstruct the stem cell therapy industry growth over the coming years.
Adult stem cell segment will witness robust growth during the forecast timeframe. It is also called as somatic stem cells found in juvenile humans and animals. Lower rejection rates, minimal ethical issues coupled with long-term renewal property related to stem cells (SCs) are factors that propels segment growth.
Musculoskeletal disorders segment accounted for considerable revenue share in 2018 owing to increasing number of commercialized stem cell therapy products for nursing of musculoskeletal disorders. Furthermore, rising musculoskeletal disorders is expected to render positive impact on segment growth during the forecast timeline.
Autologous stem cell therapy segment will witness significant growth in coming years. An autologous transplant uses a patient’s own stem cell for recovering from any diseases. Infection risk associated with this cell-based therapy is less thus, enhances its adoption that further boosts the business growth.
Cryopreservation segment will grow substantially during the analysis timeframe. It is a technique used for preserving living tissues and cells. Cryopreservation is important for all stem cell types, but it is very critical for the storage of umbilical cord blood, that rises its future demand. It is a useful technology in storing the cells and tissues for a longer period of time that further augments the segmental growth.
Bone marrow-derived mesenchymal SCs segment will grow considerably during the forecast timeframe due to its remarkable spectrum of functional properties. Bone marrow transplant is a treatment for some type of cancers such as multiple myeloma, neuroblastoma, leukemia, or other types of lymphoma that enhances the segmental growth. Moreover, protection of injured neurons as well as replacement of damaged cells are factors that will upsurge huge demand for stem cell in coming years.
North America stem cell therapy market witness robust growth over forthcoming years. The growth is attributed to rising number of clinical trials for stem cell industry and growing incidence of cancer. Moreover, ongoing research on stem cell therapy is expected to offer immense industry growth opportunities.
Few prominent players in the stem cell therapy market includes Anterogen, AlloSource, Gamida Cell, Golden Meditech, Holostem Terapie Avanzate, JCR Pharmaceuticals, MEDIPOST, NuVasive, Osiris Therapeutics, Pharmicell, RTI Surgical and VCANBIO Cell & Gene Engineering. Eminent business players focus on various strategies to maintain their position in the market. For instance, in April 2019, Golden Meditech collaborated with HKBU University, to cure neurodegenerative diseases with the help of stem cells. This collaboration is expected to assist in treatment of neurodegenerative diseases that can gain patents and research results that can benefit patients in Greater China region as well as across the globe.
Stem Cell Therapy Market By Product Type, 2014-2025 (USD Million)
- Adult stem cell
- Human embryonic stem cell
- Pluripotent stem cell
Stem Cell Therapy Market By Application, 2014-2025 (USD Million)
- Cardiovascular diseases
- Musculoskeletal disorders
- Wounds and injuries
- Gastrointestinal diseases
- Regenerative medicine
Stem Cell Therapy Market By Treatment Type, 2014-2025 (USD Million)
- Allogeneic stem cell therapy
- Autologous stem cell therapy
- Syngeneic stem cell therapy
Stem Cell Therapy Market By Technology, 2014-2025 (USD Million)
- Cell acquisition
- Cell production
Stem Cell Therapy Market By Cell Source, 2014-2025 (USD Million)
- Adipose tissue-derived mesenchymal SCs
- Bone marrow-derived mesenchymal SCs
- Embryonic SCs
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Anterogen Co, Ltd
- Gamida Cell
- Golden Meditech
- Holostem Terapie Avanzate S.r.l.
- JCR Pharmaceuticals Co., Ltd.
- MEDIPOST Co., Ltd.
- NuVasive, Inc.
- Osiris Therapeutics, Inc.
- Pharmicell Co, Ltd
- RTI Surgical, Inc
- VCANBIO Cell & Gene Engineering Corporation, Ltd
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Why Global Market Insights?Comprehensive Research
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security
Connect with our sales team